AMERICANALMANAC (Jonah Adams) - FDA panel stacked with peptide industry insiders reviews unproven injections backed by RFK Jr.
An FDA advisory panel, more than a third of whose members have financial ties to the peptide industry, opened a two-day review of seven injectable substances that lack meaningful human safety data, a process one FDA-law attorney says will likely end the way Health Secretary Robert F. Kennedy Jr. wants. The Food and Drug Administration […] The post FDA panel stacked with peptide industry insiders reviews unproven injections backed by RFK Jr. appeared first on American Almanac .
An FDA advisory panel, more than a third of whose members have financial ties to the peptide industry, opened a two-day review of seven injectable substances that lack meaningful human safety data, a process one FDA-law attorney says will likely end the way Health Secretary Robert F. Kennedy Jr. wants. The Food and Drug Administration convened twenty outside advisers in Washington this week to vote on whether seven peptides should be added to a federal list that would let compounding pharmacies legally mix and sell them by prescription. Kennedy has described himself as a "big fan" of the substances and has vowed to roll back restrictions imposed during the Biden administration. His fingerprints are on the proceeding: at least seven of the…Open